Veröffentlichungen | MDC Berlin

7 Ergebnisse:

Active Filter:

01. November 2006 in Eur J Immunol

Designer T cells by T cell receptor replacement

D. Sommermeyer
J. Neudorfer
M. Weinhold
M. Leisegang
B. Engels
E. Noessner
M.H. Heemskerk
J. Charo
D.J. Schendel
T. Blankenstein
H. Bernhard
W. Uckert

15. Mai 2006 in Cell Cycle

Reprogramming of B lymphoid cells in human lymphoma pathogenesis

M. Janz
B. Doerken
S. Mathas

01. April 2006 in Cell Death Differ

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma

I. Sturm
C. Stephan
B. Gillissen
R. Siebert
M. Janz
S. Radetzki
K. Jung
S. Loening
B. Doerken
P.T. Daniel

15. März 2006 in Blood

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells

M. Janz
M. Hummel
M. Truss
B. Wollert-Wulf
S. Mathas
K. Joehrens
C. Hagemeier
K. Bommert
H. Stein
B. Doerken
R.C. Bargou

05. Februar 2006 in Virology

Factors influencing subcellular localization of the human papillomavirus L2 minor structural protein

E. Kieback
M. Mueller

01. Februar 2006 in Nat Immunol

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

S. Mathas
M. Janz
F. Hummel
M. Hummel
B. Wollert-Wulf
S. Lusatis
I. Anagnostopoulos
A. Lietz
M. Sigvardsson
F. Jundt
K. Joehrens
K. Bommert
H. Stein
B. Doerken

01. November 2002 in Gene Ther

Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes

C. Scholz
L. Staerck
G. Willimsky
T. Blankenstein
B. Doerken
P.T. Daniel